Forbion — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Milestone Pharmaceuticalsmilestonepharma.comin𝕏Jul 2017SEC filingmedium confidence
Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
BiotechDigital HealthHealthtechMedical DevicesMontreal, US
Ela Borenstein(Director)Francis Plat(Executive Officer)Yves Rosconi(Director)Scott Weiner(Director)Martin Maguire(Executive Officer)Philippe Douville(Executive Officer, Director)
Board seatMarco Boorsma· per SEC Form D · $6.9M raise · filed Jul 2017
Co-investorsPappas Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.